B8F.DE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 04:51):

Stats
Today's Volume	41 436.00
Average Volume	10 045.00
Market Cap	18.50M
EPS	€-0.0500 ( 2023-11-28 )
Next earnings date	( €0 ) 2024-05-31
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-2.90
ATR14	€0 (0.00%)

Biofrontera AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biofrontera AG Financials

Annual	2022
Revenue:	€25.74M
Gross Profit:	€20.98M (81.52 %)
EPS:	€-0.770

Q3	2023
Revenue:	€7.02M
Gross Profit:	€5.77M (82.27 %)
EPS:	€-0.0500

Q2	2023
Revenue:	€11.99M
Gross Profit:	€9.67M (80.70 %)
EPS:	€0.00520

Q1	2023
Revenue:	€5.80M
Gross Profit:	€4.55M (78.43 %)
EPS:	€-0.0545

Financial Reports:

No articles found.

Biofrontera AG

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.